Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Carolina Mainella, Kazuo Fujihara et al.|Multiple Sclerosis and Related Disorders|2020

Cited by 41